Unknown

Dataset Information

0

AG-dependent 3'-splice sites are predisposed to aberrant splicing due to a mutation at the first nucleotide of an exon.


ABSTRACT: In pre-mRNA splicing, a conserved AG/G at the 3'-splice site is recognized by U2AF(35). A disease-causing mutation abrogating the G nucleotide at the first position of an exon (E(+1)) causes exon skipping in GH1, FECH and EYA1, but not in LPL or HEXA. Knockdown of U2AF(35) enhanced exon skipping in GH1 and FECH. RNA-EMSA revealed that wild-type FECH requires U2AF(35) but wild-type LPL does not. A series of artificial mutations in the polypyrimidine tracts of GH1, FECH, EYA1, LPL and HEXA disclosed that a stretch of at least 10-15 pyrimidines is required to ensure normal splicing in the presence of a mutation at E(+1). Analysis of nine other disease-causing mutations at E(+1) detected five splicing mutations. Our studies suggest that a mutation at the AG-dependent 3'-splice site that requires U2AF(35) for spliceosome assembly causes exon skipping, whereas one at the AG-independent 3'-splice site that does not require U2AF(35) gives rise to normal splicing. The AG-dependence of the 3'-splice site that we analyzed in disease-causing mutations at E(+1) potentially helps identify yet unrecognized splicing mutations at E(+1).

SUBMITTER: Fu Y 

PROVIDER: S-EPMC3105431 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

AG-dependent 3'-splice sites are predisposed to aberrant splicing due to a mutation at the first nucleotide of an exon.

Fu Yuan Y   Masuda Akio A   Ito Mikako M   Shinmi Jun J   Ohno Kinji K  

Nucleic acids research 20110202 10


In pre-mRNA splicing, a conserved AG/G at the 3'-splice site is recognized by U2AF(35). A disease-causing mutation abrogating the G nucleotide at the first position of an exon (E(+1)) causes exon skipping in GH1, FECH and EYA1, but not in LPL or HEXA. Knockdown of U2AF(35) enhanced exon skipping in GH1 and FECH. RNA-EMSA revealed that wild-type FECH requires U2AF(35) but wild-type LPL does not. A series of artificial mutations in the polypyrimidine tracts of GH1, FECH, EYA1, LPL and HEXA disclos  ...[more]

Similar Datasets

| S-EPMC230637 | biostudies-other
| S-EPMC7554774 | biostudies-literature
| S-EPMC7226981 | biostudies-literature
| S-EPMC1934990 | biostudies-literature
| S-EPMC1636351 | biostudies-literature
| S-EPMC2776460 | biostudies-literature
| S-EPMC4743909 | biostudies-literature
| S-EPMC1325015 | biostudies-literature
| S-EPMC5832971 | biostudies-literature
| S-EPMC5487545 | biostudies-literature